ESG

ESG

ESG

ESG

GWOXI is dedicated to advancing stem cell innovation while upholding sustainability. With over 120 patents and multiple stem cell drugs in clinical trials, we balance medical breakthroughs with social and environmental responsibility. Our efforts span green manufacturing, academic-industry collaboration, support for vulnerable groups, and strict corporate governance, ensuring that innovation, responsibility, and excellence drive both scientific progress and positive social impact.

 

Press Releases

Press Releases
NEWS
  • /userfiles/images/news/20250729055948126.jpg
    26
    2025
    09
    Press Releases
    GWOXI Stem Cell Secures Taiwan Invention Patent for Stem Cell-Derived Composition in Wound Healing

  • /userfiles/images/news/250909/20250924013519855.jpg
    09
    2025
    09
    Press Releases
    GWOXI Stem Cell Expands Cross-Border Collaborations — Engaging Potential Partners in Thailand

  • /userfiles/images/news/250822/20250924014457286.jpg
    22
    2025
    08
    Press Releases
    GWOXI Stem Cell Partners with Malaysia’s Cell 101 to Expand into the Asia-Pacific Regenerative Medicine Market